Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

5 Stocks To Buy Now That Trump Is Back in the White House

By Ujjwal Maheshwari | November 7, 2024

After months of speculating which way the US election will swing, investors are now (in light of Trump’s win) pondering which stocks will benefit. Historically Trump policies have favored deregulation of fossil fuels and infrastructure and defense spending all of which could have a substantial impact on several industries. But which specific stocks will benefit?…

Read More

Cryptocurrency in 2025: Are the Bitcoin Alternatives Worth It?

By Ujjwal Maheshwari | November 7, 2024

While cryptocurrency isn’t the diamond in the rough as it once was, its mainstream adoption has introduced new heights for this digital currency. This is especially true considering the proliferation of local and international laws and regulations made to encourage and regulate crypto adoption, as well as the hundreds of businesses around the world accepting…

Read More

Here are 5 ASX Consumer stocks defying the Cost of living crisis

By Nick Sundich | November 7, 2024

Here are 5 ASX Consumer stocks defying the Cost of living crisis!   Cash Converters (ASX:CCV) OK, there is an argument to be made that Cash Converters shouldn’t be on this list of consumer stocks doing well right now. This is because CCV is not the case of a company defying the cost of living…

Read More

Aristocrat Leisure (ASX:ALL) is one of ASX’s largest tech stocks that just happens to be in gaming

By Nick Sundich | November 7, 2024

Why has Aristocrat Leisure (ASX:ALL) succeeded where so many other gambling stocks have struggled? This company is up nearly 55% in the last 12 months and 96% in the last 5 years. Many other gaming stocks have struggled due to cost of living pressures, new restrictions and (in the case of some stocks) pecuniary penalties.…

Read More

Recce’s Phase 2 ABSSSI Clinical Trial is on Track and Producing Outstanding Results

By Nick Sundich | November 6, 2024

There are encouraging signs from Recce Pharmaceuticals‘ (ASX:RCE) Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections). The trial, is nearing completion, but the results to date have led to a Non-Data Safety Monitoring Board reviewing the trial unanimously recommending it continue. Not only have there been no serious adverse events, but…

Read More

Dominos Pizza Enterprises (ASX:DMP): Will it remain in the doldrums in FY25 as it transitions away from Don Meij?

By Nick Sundich | November 6, 2024

Dominos Pizza Enterprises (ASX:DMP) is stuck in a difficult position. Its share price is barely a quarter of its 2021 levels – how can this be when fast-food stocks are meant to be recession proof and immune to inflation? The company’s top line is proving reslient, but its bottom line…not so much. To answer the…

Read More

Maas Group (ASX:MGH) … Why investors should keep a keen eye on it in FY25!

By Nick Sundich | November 5, 2024

It is a tough time to be a construction company, but Maas Group (ASX:MGH) hasn’t fared that bad all things considered. This company, which is roughly double its IPO price, recorded another good FY24 result, and investors took note of it. But the company is still very reasonably priced.   Meet Maas Group Maas Group…

Read More

What is a dead cat bounce and how can you identify one?

By Nick Sundich | November 5, 2024

The term dead cat bounce has gained popularity in recent years. And there have been plenty of examples of this phenomenon on the ASX. So, we thought we’d write an article to explore what exactly is a dead cat bounce in relation to stock investing.   What is a dead cat bounce? The term “dead cat…

Read More

Here’s how to analyse REITs: The 5 most important things investors need to look out for

By Nick Sundich | November 4, 2024

In this article, we outline how to analyse REITs (Real Estate Investment Trusts). Despite trading no different to other listed entities, REITs are unique assets with their own metrics that investors can use to determine their performance and whether or not they are overvalued and undervalued. We outline the most important of them as well as yardsticks…

Read More

PainChek (ASX:PCK): Will 2025 be the year it finally makes progress and enters the US market?

By Nick Sundich | November 4, 2024

PainChek (ASX:PCK) has among the most admirable medical technologies there is, in the form of an app that can detect pain in non-verbal patients. Unfortunately, there has been pain for investors along the way. When it was announced that it was participating in a clinical trial the Morrison government was investing $5m in back in…

Read More

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

Highfield Resources’ (ASX:HFR) Muga Potash project is a company maker!

Highfield Resources (ASX:HFR) We spoke to Ignacio Salazar, CEO of Highfield Resources (ASX:HFR), about the recent…

Island Pharmaceuticals (ASX:ILA) is in Phase 2 with ILA-101

Island Pharmaceuticals (ASX:ILA) We spoke to Dr Paul MacLeman, Executive Chairman of Island Pharmaceuticals (ASX:ILA), about…

4DS Memory (ASX:4DS) is building momentum going into 2025

4DS Memory (ASX:4DS) We spoke with Peter Himes, CTO of 4DS Memory (ASX:4DS), about the company’s…

BluGlass (ASX:BLG): Interview with CEO Jim Haden

BluGlass (ASX:BLG) We spoke with BluGlass CEO Jim Haden, who was in Sydney for Semiconductor Australia…

Investment Glossary

Small Cap Company

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

All Ordinaries Index

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity?

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Securities

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

IPO

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.